SCHEMBL4770956

SCHEMBL4770956

[CH2][C@H](C(=O)N1CCCC1)c1ccc(-c2ncccn2)cc1

nearest known ligand 0.42

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ AVPR2 P30518 1/20 0.42
▸ OXTR P30559 1/20 0.42
▸ AVPR1A P37288 1/20 0.42
▸ HDAC4 P56524 1/20 0.40
▸ DPP4 P27487 6/20 0.39
▸ DPP7 Q9UHL4 6/20 0.39
▸ HPGD P15428 2/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ RIPK1 Q13546 2/20 0.38
▸ MAPT P10636 1/20 0.38
▸ TDP1 Q9NUW8 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ KDM4E B2RXH2 1/20 0.37
▸ ADRB2 P07550 1/20 0.37
▸ TSHR P16473 1/20 0.35
▸ SLC6A7 Q99884 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4774466 1.00 AVPR2 (0.42) AVPR2OXTRAVPR1AHDAC4DPP4
SCHEMBL4769451 0.85 ABL1 (0.48) DPP4DPP7ALDH1A1KDM4EADRB2
SCHEMBL4767002 0.85 ABL1 (0.48) DPP4DPP7ALDH1A1KDM4EADRB2
SCHEMBL6470529 0.83 DPP4 (0.44) AVPR2OXTRAVPR1AHDAC4DPP4
SCHEMBL4766524 0.79 TSHR (0.40) HPGDMAPK1ALDH1A1KDM4ETSHR
SCHEMBL6444224 0.78 HPGD (0.50) HPGDMAPTALDH1A1KDM4ETSHR
SCHEMBL4771262 0.78 HPGD (0.50) HPGDMAPTALDH1A1KDM4ETSHR
SCHEMBL5769826 0.76 NISCH (0.50) TDP1
SCHEMBL4769218 0.76 NISCH (0.50) TDP1
SCHEMBL4764604 0.75 DPP4 (0.38) DPP4DPP7HPGDMAPTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1572678-A4 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARM INC (US) 2008-05-07 — — EP claimed
EP-1572678-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-09-14 — — EP claimed
WO-2004056319-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS INC. (US) 2004-07-08 — — WO claimed
EP-1572678-A4 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARM INC (US) 2008-05-07 — — EP disclosed
EP-1572678-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-09-14 — — EP disclosed
EP-1501807-A1 SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS Elan Pharmaceuticals, Inc. (US) 2005-02-02 — — EP disclosed
WO-2004056319-A2 SUBSTITUTED N-PHENYL SULFONAMIDE BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS INC. (US) 2004-07-08 — — WO disclosed
WO-2003093245-A1 SULFONYLQUINOXALONE ACETAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BRADYKININ ANTAGONISTS ELAN PHARMACEUTICALS, INC. (US) 2003-11-13 — — WO disclosed
Send feedback